JP2014519036A - ゲムシタビンイムノアッセイ - Google Patents

ゲムシタビンイムノアッセイ Download PDF

Info

Publication number
JP2014519036A
JP2014519036A JP2014512857A JP2014512857A JP2014519036A JP 2014519036 A JP2014519036 A JP 2014519036A JP 2014512857 A JP2014512857 A JP 2014512857A JP 2014512857 A JP2014512857 A JP 2014512857A JP 2014519036 A JP2014519036 A JP 2014519036A
Authority
JP
Japan
Prior art keywords
group
gemcitabine
antibody
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014512857A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014519036A5 (https=
Inventor
サラモーン、サルヴァトーレ、ジェイ．
コートニー、ジョディ、ブレイク
サード、ハワード
スペダリーア、クリストファー
Original Assignee
サラダックス バイオメディカル インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サラダックス バイオメディカル インコーポレイテッド filed Critical サラダックス バイオメディカル インコーポレイテッド
Publication of JP2014519036A publication Critical patent/JP2014519036A/ja
Publication of JP2014519036A5 publication Critical patent/JP2014519036A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/18—Water
    • G01N33/1826—Organic contamination in water
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/18—Water
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
JP2014512857A 2011-05-24 2012-05-07 ゲムシタビンイムノアッセイ Pending JP2014519036A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13/114,218 US8426143B2 (en) 2011-05-24 2011-05-24 Gemcitabine immunoassay
US13/114,218 2011-05-24
US13/160,370 US8946392B2 (en) 2011-05-24 2011-06-14 Gemcitabine immunoassay
US13/160,370 2011-06-14
PCT/US2012/036723 WO2012161948A1 (en) 2011-05-24 2012-05-07 Gemcitabine immunoassay

Publications (2)

Publication Number Publication Date
JP2014519036A true JP2014519036A (ja) 2014-08-07
JP2014519036A5 JP2014519036A5 (https=) 2015-07-09

Family

ID=47217602

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014512857A Pending JP2014519036A (ja) 2011-05-24 2012-05-07 ゲムシタビンイムノアッセイ

Country Status (7)

Country Link
US (3) US8426143B2 (https=)
EP (1) EP2715340A4 (https=)
JP (1) JP2014519036A (https=)
CN (1) CN103782167B (https=)
BR (1) BR112013029974A2 (https=)
CA (1) CA2836539A1 (https=)
WO (1) WO2012161948A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426143B2 (en) * 2011-05-24 2013-04-23 Saladax Biomedical Inc. Gemcitabine immunoassay
DK3383406T3 (da) 2015-12-03 2022-01-10 Epidestiny Inc Sammensætninger indeholdende decitabin, 5-azacytidin og tetrahydrouridin og anvendelser deraf

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008537110A (ja) * 2005-03-30 2008-09-11 サラダックス バイオメディカル インク． ドキソルビシン免疫測定法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010200A (en) * 1932-11-17 1935-08-06 Internat Carbonic Engineering Sealing device for pressure containers
US3996344A (en) 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US4016146A (en) 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
US4269511A (en) 1979-02-15 1981-05-26 Abbott Laboratories Apparatus and method for measuring the magnitude of polarization of light
US4420568A (en) 1980-07-30 1983-12-13 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluoresceins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5101015A (en) 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
CA2096495C (en) 1992-06-16 2002-07-09 Kathy Palmer Ordonez Dual analyte immunoassay
US7829064B2 (en) 1999-05-10 2010-11-09 Immunomedics, Inc. Anti-CD74 immunoconjugates and methods
FR2836995B1 (fr) * 2002-03-05 2006-09-22 Centre Nat Rech Scient Utilisation de derives de nucleosides comportant un groupement citrate pour la production d'anticorps ayant une affinite pour des nucleosides triphosphorylees et leurs applications
US7265096B2 (en) 2002-11-04 2007-09-04 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US20060177883A1 (en) 2005-02-08 2006-08-10 Saladax Biomedical Inc. 5-Fluoro-uracil immunoassay
US8039220B2 (en) 2008-09-17 2011-10-18 Saladax Biomedical Inc. Stabilized standards for busulfan immunoassay
KR101721865B1 (ko) 2009-10-13 2017-04-03 렉산 파마슈티컬스, 인코포레이티드 항암제의 전달을 위한 폴리머 시스템
US8426143B2 (en) * 2011-05-24 2013-04-23 Saladax Biomedical Inc. Gemcitabine immunoassay

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008537110A (ja) * 2005-03-30 2008-09-11 サラダックス バイオメディカル インク． ドキソルビシン免疫測定法

Also Published As

Publication number Publication date
EP2715340A4 (en) 2014-12-31
US8426143B2 (en) 2013-04-23
US8946392B2 (en) 2015-02-03
CA2836539A1 (en) 2012-11-29
WO2012161948A1 (en) 2012-11-29
BR112013029974A2 (pt) 2017-01-31
US20120301901A1 (en) 2012-11-29
EP2715340A1 (en) 2014-04-09
CN103782167A (zh) 2014-05-07
US20120301902A1 (en) 2012-11-29
CN103782167B (zh) 2016-01-20
US20150104818A1 (en) 2015-04-16

Similar Documents

Publication Publication Date Title
US8053205B2 (en) Doxorubicin immunoassay
CN102625702B (zh) 伊马替尼免疫测定法
JP5031585B2 (ja) ５−フルオロ−ウラシル免疫測定法
JP2013522594A (ja) レナリドマイド及びサリドマイドイムノアッセイ
JP2011007807A (ja) タキソールの免疫学的検定
US20060216769A1 (en) Docetaxel immunoassay
CN103782167B (zh) 吉西他滨免疫测定
US20140273023A1 (en) Gemcitabine immunoassay
US7893220B2 (en) Busulfan immunoassay
AU2012259309A1 (en) Gemcitabine immunoassay

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150507

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150507

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150520

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160209

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160219

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160519

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161101